estrogen patch and glp 1 Menopause Patches Are in Short Supply. What Are the Alternatives? This might sound crazy, but

For randomized controlled trials, the Cochrane RoB 2.0 tool was applied across seven domains: random-sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other sources of bias

Most major GLP-1 therapies are still protected by patents in the United States

Some therapies have limited efficacy

Compounding of semaglutide will continue until at least May 22, 2025, for 503B Pharmacies (also known as 503B Outsourcing Facilities, which are compounding pharmacies that can produce large batches of medications without patient-specific prescriptions)